Fortnightly Review: The pneumococcal problem
- 15 June 1996
- Vol. 312 (7045) , 1521-1525
- https://doi.org/10.1136/bmj.312.7045.1521
Abstract
Mortality from bacteraemic pneumonia has remained unchanged at 25% over the last 40 years Globally, Streptococcus pneumoniae causes over 1 million deaths in children under the age of 5 years Antibiotic resistant strains of S pneumoniae are increasing world wide. In Spain over 50% of isolates are resistant to one or more antibiotics Patients at increased risk of severe pneumococcal infection should be:Keywords
This publication has 35 references indexed in Scilit:
- Pneumococcal disease: prospects for a new generation of vaccinesScience, 1994
- Long term management of patients after splenectomy.BMJ, 1993
- Human IgG Fc receptor heterogeneity: molecular aspects and clinical implicationsImmunology Today, 1993
- Efficacy of Pneumococcal Vaccine in High-Risk PatientsNew England Journal of Medicine, 1986
- The in-vitro activity and β-lactamase stability of carumonamJournal of Antimicrobial Chemotherapy, 1986
- The Epidemiology of Pneumococcal Disease in Infants and ChildrenClinical Infectious Diseases, 1981
- Opsonic Requirements for Intravascular Clearance after SplenectomyNew England Journal of Medicine, 1981
- Correlation between Serum IgG-2 Concentrations and the Antibody Response to Bacterial Polysaccharide AntigensNew England Journal of Medicine, 1980
- SOME BIOLOGICAL PROPERTIES OF PNEUMOCOCCUS TYPE 37 AND THE CHEMISTRY OF ITS CAPSULAR POLYSACCHARIDEThe Journal of Experimental Medicine, 1970
- PATHOGENESIS OF PNEUMOCOCCUS INFECTIONS IN MICEThe Journal of Experimental Medicine, 1936